Pfizer (PFE) Appoints Aamir Malik as Chief Business Innovation Officer

Pfizer (PFE) Announces Positive Results from Phase 3 JADE DARE Trial Comparing the Efficacy of Abrocitinib and Dupilumab for Moderate to Severe Atopic Dermatitis

Pfizer Inc. (NYSE: PFE) today announced that JADE DARE (B7451050), a 26-week, randomized, double-blind, double-dummy, active-controlled, multi-center Phase 3 study, met its co-primary and key secondary efficacy endpoints. The study showed that abrocitinib was statistically superior compared to dupilumab in each evaluated efficacy measure and had a safety profile consistent with previous studies. The head-to-head study was... More

Pfizer (PFE) and BioNTech(BTNX) Partner With Eurofarma Laboratórios to Manufacture COVID-19 Vaccine in Latin America

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the signing of a letter of intent with Eurofarma Laboratórios SA, a Brazilian biopharmaceutical company, to manufacture COMIRNATY® (COVID-19 Vaccine, mRNA) for distribution within Latin America.

Eurofarma will perform manufacturing activities within Pfizers and BioNTechs global COVID-19 vaccine supply chain and manufacturing network, which will now span four continents and include more than 20 manufacturing facilities. To facilitate Eurofarmas involvement in the process, technical transfer, on-site development, and equipment installation activities will begin immediately.... More

Biden Admin. Plans Covid-19 Boosters at Six Months, Had Previously Said Booster Would Start at Eight Months After Inoculation - DJ

Biden Admin. Plans Covid-19 Boosters at Six Months, Had Previously Said Booster Would Start at Eight Months After Inoculation - DJ

Pfizer seeks U.S. approval for COVID vaccine booster

(Reuters) -Pfizer Inc on Wednesday said a booster dose of its two-shot COVID-19 vaccine spurs a more than threefold increase in antibodies against the coronavirus, as the company seeks U.S. regulatory approval for a third injection.

The drugmaker and its German partner BioNTech SE aim to complete the submission for use of booster shots in people aged 16 and over by the end of this week.

The U.S. government has said it was gearing up https://www.reuters.com/world/us/us-begin-offering-covid-19-vaccine-booster-shots-september-2021-08-18 to roll out the third shot of vaccines from both... More

Pfizer (PFE), BioNTech (BNTX) Confirm Rolling Submission of sBLA to U.S. FDA for Booster Dose of Covid-19 Vaccine

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the initiation of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for the approval of a booster (third) dose of COMIRNATY® (COVID-19 Vaccine, mRNA) to prevent COVID-19 in individuals 16 years of age and older. The companies intend to complete submission of the sBLA by the end of this week.

The sBLA includes data from a Phase 3 clinical trial of 306 participants 18-55 years of age who received a booster (third)... More

Pfizer (PFE), BioNTech (BNTX) Start Rolling Submission to FDA for Booster - Bloomberg

(Updated - August 25, 2021 12:04 PM EDT)

Pfizer (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) started their rolling submission to the FDA for booster vaccines, Bloomberg reported. The companies intend to finish the sBLA submissions by... More

Pentagon makes Pfizer vaccine mandatory after FDA approval- memo

WASHINGTON (Reuters) -The Pentagon on Wednesday ordered all active-duty service members to be vaccinated with the Pfizer/BioNTech COVID-19 vaccine days after the Food and Drug Administration granted it full approval.

In a memo seen by Reuters, the Pentagon ordered the military to start the process immediately but did not put a specific timeline on when it... More